Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tami L Mark

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
Drug and Alcohol Dependence|September 6, 2003
Understanding US addiction physicians' low rate of naltrexone prescriptionTami L Mark, Henry R Kranzler, Xue Song
JAMA|July 10, 2019
Association Between Medicare and FDA Policies and Prior Authorization Requirements for Buprenorphine Products in Medicare Part D PlansTami L Mark, William Parish, Gary A Zarkin
Psychiatric Services (Washington, D.C.)|September 3, 2009
Datapoints: psychotropic drug prescriptions by medical specialtyTami L Mark, Katharine R Levit, Jeffrey A Buck
Journal of Substance Abuse Treatment|December 26, 2012
Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphineTami L Mark, Joan Dilonardo, Rita Vandivort, et al.
Journal of Cataract and Refractive Surgery|April 26, 2002
Axial length in applanation tonometryHarry H Mark, Kim P Robbins, Tami L Mark
Technology in Cancer Research & Treatment|September 12, 2008
The benefits and challenges of using computer-assisted symptom assessments in oncology clinics: results of a qualitative assessmentTami L Mark, Gina Johnson, Barry Fortner, et al.
The American Journal of Managed Care|March 17, 2009
The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expendituresTami L Mark, Teresa B Gibson, Kimberly A McGuigan
Journal of Substance Abuse Treatment|November 7, 2006
Factors affecting detoxification readmission: analysis of public sector data from three statesTami L Mark, Rita Vandivort-Warren, Leslie B Montejano
JAMA Network Open|April 21, 2020
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare BeneficiariesTami L Mark, William J Parish, Gary A Zarkin
Health Affairs (Project Hope)|March 18, 2026
US National Spending On Mental Health And Substance Use Disorder Treatment Driven By Case Growth, 2000-21Tami L Mark, Lasanthi Fernando, Peter Shieh, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
Drug and Alcohol Dependence|September 6, 2003
Understanding US addiction physicians' low rate of naltrexone prescriptionTami L Mark, Henry R Kranzler, Xue Song
JAMA|July 10, 2019
Association Between Medicare and FDA Policies and Prior Authorization Requirements for Buprenorphine Products in Medicare Part D PlansTami L Mark, William Parish, Gary A Zarkin
Psychiatric Services (Washington, D.C.)|September 3, 2009
Datapoints: psychotropic drug prescriptions by medical specialtyTami L Mark, Katharine R Levit, Jeffrey A Buck
Journal of Substance Abuse Treatment|December 26, 2012
Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphineTami L Mark, Joan Dilonardo, Rita Vandivort, et al.
Journal of Cataract and Refractive Surgery|April 26, 2002
Axial length in applanation tonometryHarry H Mark, Kim P Robbins, Tami L Mark
Technology in Cancer Research & Treatment|September 12, 2008
The benefits and challenges of using computer-assisted symptom assessments in oncology clinics: results of a qualitative assessmentTami L Mark, Gina Johnson, Barry Fortner, et al.
The American Journal of Managed Care|March 17, 2009
The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expendituresTami L Mark, Teresa B Gibson, Kimberly A McGuigan
Journal of Substance Abuse Treatment|November 7, 2006
Factors affecting detoxification readmission: analysis of public sector data from three statesTami L Mark, Rita Vandivort-Warren, Leslie B Montejano
JAMA Network Open|April 21, 2020
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare BeneficiariesTami L Mark, William J Parish, Gary A Zarkin
Health Affairs (Project Hope)|March 18, 2026
US National Spending On Mental Health And Substance Use Disorder Treatment Driven By Case Growth, 2000-21Tami L Mark, Lasanthi Fernando, Peter Shieh, et al.
Pageof 13